Results for tag: "Hypotrichosis Drug"

The Hypotrichosis Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. Hypotrichosis is a condition characterized by sparse or absent hair growth. Drugs used to treat this condition are typically topical formulations, such as creams, lotions, and ointments. These drugs work by stimulating hair growth and reducing inflammation. Common active ingredients in these drugs include minoxidil, finasteride, and corticosteroids. Other drugs used to treat hypotrichosis include topical retinoids, topical immunomodulators, and topical anti-androgens. Some companies in the Hypotrichosis Drug market include Johnson & Johnson, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more